secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (—)
CIK:        0001419051
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001493152-25-001670
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Therapeutic Solutions International increases authorized common stock from 6.5B to 9.0B shares
--------------------------------------------------------------------------------

- Authorized common stock increased from 6.5 billion to 9.0 billion shares (par $0.001) via Certificate of Amendment filed Jan 7, 2025.
- Amendment approved by nonunanimous majority written consent of stockholders; Series A Preferred holder has effective voting control.
- Series A Preferred (held by Timothy G. Dixon and Thomas E. Ichim) votes 1M + fully diluted common votes, ensuring control.
- Preferred stock authorization unchanged at 5 million shares; no change to fiscal year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419051/000149315225001670/0001493152-25-001670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419051/000149315225001670/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer